A Gene Transfer Study Using Experimental SPK-8011 for Hemophilia A (poor blood clotting)
This research study will help us learn if the study product (SPK-8011) is safe and effective in reducing bleeding for treating hemophilia A.
a study on Hemophilia
Hemophilia A Adeno-Associated Virus (AAV) Blood Coagulation Disorders Blood Coagulation Disorders, Inherited Coagulation Protein Disorders Factor VIII (FVIII) Factor VIII (FVIII) Deficiency Factor VIII (FVIII) Gene Factor VIII (FVIII) Protein Genetic Diseases, Inborn Genetic Diseases, X-Linked Gene Therapy Gene Transfer Hematologic Diseases Hemorrhagic Disorders Recombinant Vector SPK-8011
Lead Scientist at UC Davis
- Adam Giermasz, MD, PhD
Associate Professor, Hematology and Oncology. Authored (or co-authored) 47 research publications